Ming Ji Selected Research

Neoplasm Metastasis (Metastasis)

9/2020	Targeted delivery of chlorogenic acid by mannosylated liposomes to effectively promote the polarization of TAMs for the treatment of glioblastoma.
5/2016	Poly (ADP-ribose) polymerases inhibitor, Zj6413, as a potential therapeutic agent against breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming Ji Research Topics

Disease

48	Neoplasms (Cancer) 02/2024 - 01/2002
8	Weight Loss (Weight Reduction) 02/2024 - 09/2002
8	Hypoxia (Hypoxemia) 01/2023 - 09/2002
7	Breast Neoplasms (Breast Cancer) 05/2023 - 01/2016
6	Inflammation (Inflammations) 01/2024 - 03/2015
6	Glioblastoma (Glioblastoma Multiforme) 02/2022 - 01/2017
4	Asthma (Bronchial Asthma) 12/2023 - 01/2016
4	Infections 05/2023 - 10/2014
4	Fibrosis (Cirrhosis) 03/2023 - 12/2013
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 04/2023 - 07/2015
3	Glioma (Gliomas) 02/2022 - 01/2019
3	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 02/2017
3	Carcinogenesis 01/2021 - 10/2012
3	Prostatic Neoplasms (Prostate Cancer) 12/2020 - 05/2008
3	Type 2 Diabetes Mellitus (MODY) 11/2017 - 04/2005
2	Thinness 03/2024 - 03/2024
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2024 - 04/2018
2	Stomach Neoplasms (Stomach Cancer) 04/2023 - 01/2021
2	Cognitive Dysfunction 04/2023 - 09/2019
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2022 - 10/2019
2	Ischemic Stroke 01/2022 - 01/2021
2	Body Weight (Weight, Body) 01/2022 - 03/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020 - 05/2020
2	Neoplasm Metastasis (Metastasis) 09/2020 - 05/2016
2	Adenoma (Adenomas) 05/2019 - 02/2017
2	Pain (Aches) 01/2019 - 12/2016
2	Triple Negative Breast Neoplasms 12/2018 - 05/2016
2	Autistic Disorder (Autism) 05/2008 - 09/2006
1	Obesity 04/2024
1	Overweight 04/2024
1	Lung Neoplasms (Lung Cancer) 01/2024
1	Adenocarcinoma of Lung 01/2024
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023
1	Neuroblastoma 06/2023

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2012
6	Cytotoxins (Cytolysins)IBA 06/2011 - 01/2002
5	Paclitaxel (Taxol)FDA LinkGeneric 05/2023 - 01/2002
5	4- (3- (2- nitro- 1- imidazolyl)- propylamino)- 7- chloroquinoline hydrochlorideIBA 06/2011 - 01/2002
4	Chlorogenic AcidIBA 06/2023 - 01/2017
4	EnzymesIBA 04/2023 - 01/2003
4	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2023 - 09/2015
4	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 12/2012
3	Methionine (L-Methionine)FDA Link 02/2024 - 01/2020
3	CytokinesIBA 01/2024 - 01/2023
3	Antineoplastic Agents (Antineoplastics)IBA 11/2023 - 12/2018
3	ProdrugsIBA 07/2023 - 01/2018
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2023 - 09/2015
3	Therapeutic UsesIBA 04/2023 - 01/2019
3	NucleotidesIBA 04/2023 - 01/2022
3	InflammasomesIBA 04/2023 - 01/2022
3	GlucocorticoidsIBA 01/2023 - 01/2019
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 01/2016
3	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 05/2016
3	MicroRNAs (MicroRNA)IBA 05/2019 - 10/2011
2	SilverIBA 03/2024 - 03/2024
2	Histone Deacetylase InhibitorsIBA 01/2024 - 01/2021
2	benzamideIBA 11/2023 - 12/2022
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2023 - 07/2018
2	alpha Catenin (alpha E-Catenin)IBA 09/2023 - 01/2023
2	Tubulin ModulatorsIBA 05/2023 - 12/2022
2	LeptinIBA 04/2023 - 01/2023
2	Bleomycin (Blenoxane)FDA LinkGeneric 03/2023 - 10/2019
2	Sorafenib (BAY 43-9006)FDA Link 01/2023 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2023
2	Phosphotransferases (Kinase)IBA 01/2023 - 03/2011
2	TubulinIBA 12/2022 - 12/2020
2	Colchicine FDA LinkGeneric 12/2022 - 12/2020
2	AntibodiesIBA 06/2022 - 10/2014
2	CholesterolIBA 01/2022 - 03/2015
2	N-dodecyl-L-lysine amideIBA 01/2022 - 11/2021
2	CateninsIBA 01/2021 - 01/2017
2	IronIBA 01/2021 - 01/2021
2	Liposomes (Liposome)IBA 09/2020 - 01/2019
2	Mannose ReceptorIBA 09/2020 - 01/2019
2	Sphingosine-1-Phosphate ReceptorsIBA 01/2019 - 04/2018
2	C-Reactive ProteinIBA 12/2016 - 03/2015
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 05/2016 - 12/2012
2	AntigensIBA 01/2016 - 05/2008
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2011 - 09/2002
2	Tirapazamine (SR 4233)IBA 12/2002 - 09/2002
1	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 04/2024
1	Protein Tyrosine PhosphatasesIBA 01/2024
1	Histones (Histone)IBA 01/2024
1	Mitogen-Activated Protein KinasesIBA 01/2024
1	SHP099IBA 01/2024
1	Class 7 Receptor-Like Protein Tyrosine PhosphatasesIBA 01/2024
1	Bombesin Receptors (Bombesin Receptor)IBA 01/2024
1	Imiquimod (Aldara)FDA LinkGeneric 01/2024
1	IntegrinsIBA 12/2023
1	QuinazolinesIBA 11/2023
1	ZincIBA 11/2023
1	Fluorescent Dyes (Fluorescent Probes)IBA 08/2023
1	Thiamine (Aneurin)FDA Link 06/2023

Therapy/Procedure

19	Therapeutics 02/2024 - 02/2017
7	Bariatric Surgery 02/2024 - 01/2021
5	Immunotherapy 01/2023 - 09/2020
5	Drug Therapy (Chemotherapy) 04/2022 - 09/2002
3	Oral Administration 02/2022 - 12/2020
2	Length of Stay 05/2020 - 04/2019
2	Radiotherapy 01/2016 - 12/2013